SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001823239-21-000025
Filing Date
2021-11-10
Accepted
2021-11-10 16:09:12
Documents
13
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20211110.htm   iXBRL 8-K 41233
2 EX-99.1 exhibit991-q32021.htm EX-99.1 198488
  Complete submission text file 0001823239-21-000025.txt   404651

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20211110.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20211110_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20211110_pre.xml EX-101.PRE 13579
6 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20211110_htm.xml XML 12482
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 211396634
SIC: 2834 Pharmaceutical Preparations